X4 Pharmaceuticals, Inc (XFOR) stock
XFORNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$3.12−0.05 (-1.58%)
Close on Nov 13, 2026Market cap $309.34MP/E –Yield –
X4 Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
X4 Pharmaceuticals's enterprise value was $102.45M on Nov 11, 2026, against -$30.67M a year earlier. Over the last 5 years it ranged from -$84.66M to $206.77M, with a median of $54.39K.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $102.45M | – |
| 2025 | Dec 31, 2025 | -$21.61M | – |
| 2024 | Dec 31, 2024 | -$11.37M | – |
| 2023 | Dec 29, 2023 | -$2.66M | -253.3% |
| 2022 | Dec 30, 2022 | $1.73M | – |
| 2021 | Dec 31, 2021 | -$20.44M | -228.4% |
| 2020 | Dec 31, 2020 | $15.92M | -79.3% |
| 2019 | Dec 31, 2019 | $76.83M | – |
| 2018 | Dec 31, 2018 | -$3.41M | – |
| 2017 | Dec 29, 2017 | -$13.89M | – |
See a number that looks wrong?